UiPath Inc. (NYSE:PATH) Shares Acquired by Credit Suisse AG

Credit Suisse AG increased its stake in shares of UiPath Inc. (NYSE:PATH – Get Rating) by 72.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 108,067 shares of the healthcare company’s stock after acquiring an additional 45,452 shares during the quarter. Credit Suisse AG’s holdings in UiPath were worth $1,363,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. SeaCrest Wealth Management LLC purchased a new stake in shares of UiPath in the 2nd quarter valued at about $25,000. Householder Group Estate & Retirement Specialist LLC purchased a new stake in UiPath in the third quarter valued at approximately $25,000. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of UiPath in the second quarter valued at approximately $59,000. American International Group Inc. purchased a new position in shares of UiPath during the second quarter worth approximately $74,000. Finally, CWM LLC increased its holdings in shares of UiPath by 191.0% in the 3rd quarter. CWM LLC now owns 6,451 shares of the healthcare company’s stock valued at $81,000 after acquiring an additional 4,234 shares during the period. 56.40% of the stock is owned by hedge funds and other institutional investors.

UiPath Stock Performance

Shares of PATH stock opened at $15.44 on Thursday. The stock has a fifty day moving average price of $14.66 and a 200 day moving average price of $13.69. The stock has a market cap of $8.54 billion, a PE ratio of -23.04 and a beta of 0.60. UiPath Inc. has a 1 year low of $10.40 and a 1 year high of $31.88.

Analyst Ratings Changes

Several brokerages have issued reports on PATH. Royal Bank of Canada lowered their price objective on shares of UiPath from $16.00 to $15.00 and set a “sector perform” rating on the stock in a research report on Monday, November 28th. Wells Fargo & Company increased their price objective on UiPath from $16.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday, December 2nd. Credit Suisse Group dropped their target price on UiPath from $30.00 to $27.50 and set an “outperform” rating on the stock in a report on Wednesday, November 16th. Evercore ISI decreased their price target on UiPath to $17.00 in a report on Friday, December 2nd. Finally, Barclays lowered their price objective on shares of UiPath from $15.00 to $13.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 10th. Nine equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $17.97.

Insider Activity

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction dated Wednesday, February 15th. The shares were sold at an average price of $16.61, for a total value of $664,400.00. Following the sale, the chief financial officer now owns 1,359,051 shares of the company’s stock, valued at $22,573,837.11. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 31.88% of the company’s stock.

About UiPath

(Get Rating)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.